Katherine D. Holland, MD, PhD

Pediatric Epileptologist, Division of Neurology

Associate Professor, UC Department of Pediatrics

Mechanisms of epileptogenesis

MD: Washington University, St Louis MO, 1991.

PhD (pharmacology): Washington University, St Louis MO, 1991.

Internship: Children's Hospital, Boston MA.

Residency: St Louis Children's Hospital, St Louis, MO.

Certification: Neurology with added qualification in pediatric neurology, 2000.
Standridge SM, Holland KD, Horn PS. Cardiac arrhythmias and ictal events within an epilepsy monitoring unit. Pediatr Neurol. 2010 Mar;42(3):201-5.

Holland KD, Monahan S, Morita D, Vartzelis G, Glauser TA. Valproate in children with newly diagnosed idiopathic generalized epilepsyActa Neurol Scand. 2010 Mar;121(3):149-53.

Holland KD, Kearney JA, Glauser TA, Buck G, Keddache M, Blankston JR, Glaaser IW, Kass RS, Meisler MH. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. Neurosci Lett. 2008 Mar 5;433(1):65-70.

Holland KD, Glauser TA. Response to carbamazepine in children with newly diagnosed partial onset epilepsyNeurology. 2007 Aug 7;69(6):596-9.

Holland KD, Fleming MT, Cheek S, Moran JL, Beier DR, Meisler MH. De novo exon duplication in a new allele of mouse Glra1 (spasmodic)Genetics. 2006 Dec;174(4):2245-7.